MiraLax (polyethylene glycol) product image

Available to sourceHuman Prescription DrugGastrointestinal

GAVILYTE G (polyethylene glycol-3350 and Electrolytes)

Active ingredients · Polyethylene Glycol 3350, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride, Sodium Sulfate Anhydrous

236 g/274.31g / 2.97 g/274.31g / 6.74 g/274.31g / 5.86 g/274.31g / 22.74 g/274.31g · Powder for Solution

By Lupin Pharmaceuticals,Inc.

NDC: 43386-090
Route: Oral
Therapeutic class: Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Potassium Compounds [CS], Potassium Salt , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing category: ANDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.